MeSH term | MeSH ID | Detail |
---|---|---|
Abnormalities, Multiple | D000015 | 13 associated lipids |
Abnormalities, Drug-Induced | D000014 | 10 associated lipids |
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with erythromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
LEE CC et al. | Distribution and excretion of radioactivity in rats receiving N-methyl-C14-erythromycin. | 1956 | J. Pharmacol. Exp. Ther. | pmid:13332572 |
LEE CC et al. | The excretory products of N-methyl-C14-erythromycin in rats. | 1956 | J. Pharmacol. Exp. Ther. | pmid:13332573 |
COMINAZZINI C | [Treatment of carriers of Corynebacterium diphtheriae with erythromycin]. | 1956 | Osp Maggiore | pmid:13335237 |
MARTINEZ DE LA CERDA M | [Erythromycin in the treatment of neurosyphilis]. | 1956 | Rev Med Cubana | pmid:13336744 |
PREISLER O | [Blood picture of the antibiotic, erythromycin, after peroral administration and its excretion in human milk]. | 1956 | Zentralbl Gynakol | pmid:13338737 |
CHABBERT Y | Not Available | 1956 | Ann Inst Pasteur (Paris) | pmid:13340322 |
ZELENKA et al. | [Polymyxin and erythromycin in pediatric practice]. | 1956 | Cesk Pediatr | pmid:13343357 |
LOPEZ-BELIO M et al. | Erythromycin as prophylaxis in pulmonary resection. | 1956 | J Thorac Surg | pmid:13346792 |
TETZNER KH | [Antibiotic treatment with erycinum]. | 1956 | Medizinische | pmid:13347850 |
BLOEDNER CD | [Intramuscular administration of erythromycin]. | 1956 | Med. Klin. (Munich) | pmid:13348001 |
CASTELLON M and PRATS F | [Ilotycin (erythromycin) in the treatment of recent syphilis; preliminary experience]. | 1956 | Rev Med Chil | pmid:13371006 |
ERYTHROMYCIN prophylaxis against ophthalmia neonatorum. | 1956 | Whats New | pmid:24544143 | |
OSKAM HJ | Determination of the sensitivity of bacteria to combinations of antibiotics in vitro; discussion of some results, especially with the combination tetracyclin-erythromycin. | 1956 | Acta Med Scand | pmid:13372188 |
BERNAY P | [Enterotoxicosis due to Micrococcus pyogenes aureus after sanclomycin treatment; cure by erythromycin]. | 1956 | Arch Mal Appar Dig Mal Nutr | pmid:13373476 |
MUSSGNUG G | [Not Available]. | 1956 | Arzneimittelforschung | pmid:13373647 |
RUBINSTEIN P | [Medical treatment of pyogenous pulmonary abscess by antibiotics]. | 1956 | Prensa Med Argent | pmid:13379170 |
CICCANTELLI MJ and GARRY MW | Erythromycin: an evaluation for clinical toxicity. | 1956 | Am. J. Med. Sci. | pmid:13362260 |
PELNER L and PUDERBACH W | Pseudomembranous staphylococcal enterocolitis: recovery in two patients treated with erythromycin; some notes on antibiotic resistance. | 1956 | Am Pract Dig Treat | pmid:13362857 |
FINLAND M and JONES WF | Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasms of normal subjects after ingestion of erythromycin or penicillin or both. | 1956 | N. Engl. J. Med. | pmid:13378603 |
FULLERTON JM and SMITH AJ | Rapid changes in sensitivity to streptomycin and erythromycin in staphylococcal septicaemia. | 1956 | Lancet | pmid:13368527 |